Posted on 6/18/20
Better Coronavirus Stock: Regeneron or Gilead Sciences?
Though much attention has been paid to the development of a coronavirus vaccine in the past weeks, companies that are focused on treatments are also making . . .
Posted on 6/17/20
IVERIC bio Proposes Offering of Common Stock
NEW YORK--(BUSINESS WIRE)--IVERIC bio, Inc. (Nasdaq: ISEE), today announced that it is commencing an underwritten public offering of $50.0 million of shares of its common stock. . . .
Posted on 6/17/20
Provention Bio Announces Proposed Public Offering of Common Stock
Provention Bio, Inc., (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that it has commenced an underwritten public offering of . . .
Posted on 6/17/20
Actinium Pharmaceuticals Announces Proposed Public Offering
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) today announced that it intends to offer and sell shares of its common stock (or common stock equivalents in lieu . . .
Posted on 6/17/20
Actinium Pharmaceuticals Announces Pricing of $25.0 Million Public Offering
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) today announced the pricing of its previously announced public offering of 76,923,077 shares of its common stock at a price to . . .
Posted on 6/17/20
Phosphorus Announces Partnership With BioIQ
Phosphorus, a leading genomics firm headquartered in New York City with a laboratory in Secaucus, New Jersey, announced today a partnership with BioIQ, a healthcare engagement . . .
Posted on 6/17/20
TapestryHealth Purchases Telehealth Software Leader
As part of the purchase, Stefan Alexa, former Chief Technical Officer at Telemedicine Web Services and the architect behind TapestryHealth's proprietary platform, will be joining TapestryHealth . . .
Posted on 6/17/20
Merck Prices $4.5 Billion Debt Offering
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, yesterday priced a $4.5 billion public offering of four series of senior . . .
Posted on 6/16/20
Cohen Children’s Medical Center Ranked One of Nation’s Best by US News
NEW HYDE PARK, N.Y.--(BUSINESS WIRE)--Cohen Children’s Medical Center has earned top 40 national rankings for exceptional care in nine pediatric specialties – the most in the . . .
Posted on 6/16/20
Bristol Myers Squibb Announces Commencement of Registered Exchange Offers
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today the commencement of its offers to exchange any and all of its outstanding (i) $19,000,000,000 aggregate principal amount . . .
Posted on 6/16/20
Fusion Pharmaceuticals IPO: Say No To One-Product Biotech IPOs
SummaryFusion Pharmaceuticals has filed for a $100 million IPO, which it intends to use to further developments into its new drug.Its main drug, FPI-1434, has immense . . .
Posted on 6/15/20
Longhorn Vaccines and Diagnostics and Greenfield Global Partner
Longhorn Vaccines & Diagnostics, an innovative molecular tool, assay and vaccine development company, and Pharmco, Greenfield Global's popular brand of specialty alcohols and high-purity solvents, have . . .
Posted on 6/15/20
Cigna Foundation Announces Availability Of $5 Million In Grants
The Cigna Foundation is inviting nonprofits working to create greater access to mental health services to apply for funding through its Healthier Kids For Our FutureSM . . .
Posted on 6/15/20
bluebird bio Reports Dramatic Improvement in Sickle Cell Patients with LentiGlobin Gene Therapy
Gene therapy company bluebird bio (NASDAQ:BLUE) gave an update on the clinical trial of its treatment for sickle cell disease (SCD) showing that patients in the . . .
Posted on 6/15/20
Is Merck A Great Dividend Stock?
Investors shouldn't settle for just an average dividend stock, certainly not during the COVID-19 pandemic when many dividend stocks are proving to be unstable. Instead, investors . . .
Posted on 6/14/20
Dr. Reddy's Laboratories Enters into a Licensing Agreement with Gilead Sciences for Remdesivir
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today . . .
Posted on 6/12/20
Royalty Pharma Announce $255 Million Purchase Agreement
CAMBRIDGE, Mass. and NEW YORK, June 12, 2020 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism to treat . . .
Posted on 6/12/20
Better Buy: bluebird bio vs. Gilead Sciences
Gilead Sciences (NASDAQ:GILD) has been leading the hunt to find a treatment for COVID-19. As a result, shares of the company have performed well of late . . .
Posted on 6/12/20
Regeneron Begins Human Trials of a Potential COVID-19 Treatment
Another new COVID-19 treatment candidate entered clinical-stage testing on Thursday. Regeneron (NASDAQ:REGN) has started a human trial of REGN-COV2, a pair of antibodies that glom onto . . .
Posted on 6/11/20
The #1 Pick In Health Care: Johnson & Johnson
The leading diversified consumer health brand, pharmaceutical producer and medical device maker, all rolled into one simple investment is available at a fair quote in early . . .
Posted on 6/11/20
Fosun Launches Partnership With Sing For Hope To Benefit Health Care Workers At Local Hospitals
Fosun and Sing for Hope to Provide 10-Minute Sing for Hope gramsto Essential Workers at Four Hospitals Fosun, a global investment entity and owner of the . . .
Posted on 6/11/20
Reata Pharmaceuticals and Blackstone Life Sciences Announce $350 Million Investment
Blackstone (NYSE: BX) and Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today announced that funds managed by Blackstone Life Sciences
Posted on 6/11/20
Here's Why The Clouds Have Lifted For Quest Diagnostics
After hitting its 52-week low in April, Quest Diagnostics (NYSE:DGX) has seen its stock recover nicely, even beating the S&P 500 year to date. This diagnostic . . .
Posted on 6/11/20
Johnson & Johnson to Begin Coronavirus Vaccine Clinical Trial in July
Johnson & Johnson (NYSE:JNJ) announced on Wednesday that it expects to begin a phase 1/2a clinical trial of its COVID-19 vaccine candidate Ad26.COV2-S, recombinant, in the . . .
Posted on 6/10/20
DelMar to Acquire Adgero Biopharmaceuticals
DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) and Adgero Biopharmaceuticals Holdings, Inc. today announced the companies have entered into a definitive merger agreement
New York
